Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
36th EORTC-NCI-AACR Symposium
ACS Clinical Congress 2024
SOHO 2024
Timely Topics
2024 ASTRO Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Topics
Advertisement
Solid Tumors
Bladder Cancer
Breast Cancer
CNS Cancers
Colorectal Cancer
Gastroesophageal Cancer
Gastrointestinal Cancer
Gynecologic Cancers
Head and Neck Cancer
Hepatobiliary Cancer
Kidney Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Thyroid Cancer
Neuroendocrine Tumors
Hematologic Malignancies
Leukemia
Lymphoma
Lymphoma (Curated)
Multiple Myeloma
Myelodysplastic Syndromes
Issues in Oncology
Cardio-oncology
Cost of Care
COVID-19
Genomics/Genetics
Geriatric Oncology
Global Cancer Care
Health-Care Policy
Immunotherapy
Legislation
Survivorship
Supportive Care
Integrative Oncology
Pain Management
Palliative Care
Symptom Management
Advertisement
Advertisement
Oct
29
Today In Oncology
ECOG ACRIN Cancer Research Group Caris Life Sciences Partner to Learn More From TAILORx Trial
Early Results Show Novel Agent Has Clinical Activity in FGFR3-Driven Advanced Bladder Cancer
Scientists Develop a ‘Digital Twin’ Model to Predict Cancer Treatment Responses
Addition of Induction Chemotherapy to Standard Chemoradiotherapy in Locally Advanced Cervical Cancer
Immunotherapy Plus Targeted Therapy for Anaplastic Thyroid Carcinoma
View More
Advertisement